Literature DB >> 26916807

Epidemiology of laboratory-confirmed respiratory syncytial virus infection in young children in England, 2010-2014: the importance of birth month.

R M Reeves1, P Hardelid1, R Gilbert1, J Ellis2, H Zhao3, M Donati4, R Pebody3.   

Abstract

The epidemiology of laboratory-confirmed respiratory syncytial virus (RSV) infections in young children has not recently been described in England, and is an essential step in identifying optimal target groups for future licensed RSV vaccines. We used two laboratory surveillance systems to examine the total number and number of positive RSV tests in children aged <5 years in England from 2010 to 2014. We derived odds ratios (ORs) with 95% confidence intervals (CIs) comparing children by birth month, using multivariable logistic regression models adjusted for age, season and sex. Forty-seven percent of RSV tests (29 851/63 827) and 57% (7405/13 034) of positive results in children aged <5 years were in infants aged <6 months. Moreover, 38% (4982/13 034) of positive results were in infants aged <3 months. Infants born in September, October and November had the highest odds of a positive RSV test during their first year of life compared to infants born in January (OR 2·1, 95% CI 1·7-2·7; OR 2·4, 95% CI 2·1-2·8; and OR 2·4, 95% CI 2·1-2·7, respectively). Our results highlight the importance of young age and birth month near the beginning of the RSV season to the risk of laboratory-confirmed RSV infection. Future control measures should consider protection for these groups.

Entities:  

Keywords:  Children; England; epidemiology; laboratory-confirmed; respiratory syncytial virus

Mesh:

Year:  2016        PMID: 26916807      PMCID: PMC9150574          DOI: 10.1017/S0950268816000352

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  25 in total

1.  Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998.

Authors:  B Müller-Pebody; W J Edmunds; M C Zambon; N J Gay; N S Crowcroft
Journal:  Epidemiol Infect       Date:  2002-08       Impact factor: 2.451

2.  Clinical prediction rule for RSV bronchiolitis in healthy newborns: prognostic birth cohort study.

Authors:  Michiel L Houben; Louis Bont; Berry Wilbrink; Mirjam E Belderbos; Jan L L Kimpen; Gerard H A Visser; Maroeska M Rovers
Journal:  Pediatrics       Date:  2010-12-27       Impact factor: 7.124

3.  Assessing the burden of influenza and other respiratory infections in England and Wales.

Authors:  R J Pitman; A Melegaro; D Gelb; M R Siddiqui; N J Gay; W J Edmunds
Journal:  J Infect       Date:  2006-11-09       Impact factor: 6.072

4.  Progress and challenges in RSV prophylaxis and vaccine development.

Authors:  Lia M Haynes
Journal:  J Infect Dis       Date:  2013-12-15       Impact factor: 5.226

Review 5.  Respiratory syncytial virus vaccine development.

Authors:  Larry J Anderson
Journal:  Semin Immunol       Date:  2013-06-15       Impact factor: 11.130

6.  RSV--still more questions than answers.

Authors:  Louis Bont; Eugenio Baraldi; Brigitte Fauroux; Anne Greenough; Terho Heikkinen; Paolo Manzoni; Federico Martinón-Torres; Harish Nair; Nikolaos G Papadopoulos
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

7.  Risk factors for severe respiratory syncytial virus lower respiratory tract infection.

Authors:  Constanze Sommer; Bernhard Resch; Eric A F Simões
Journal:  Open Microbiol J       Date:  2011-12-30

8.  Respiratory syncytial virus surveillance in the United States, 2007-2012: results from a national surveillance system.

Authors:  Catherine Balderston McGuiness; Marnie L Boron; Brett Saunders; Laurel Edelman; Veena R Kumar; Karma M Rabon-Stith
Journal:  Pediatr Infect Dis J       Date:  2014-06       Impact factor: 2.129

9.  Use of data linkage to investigate the aetiology of acute lower respiratory infection hospitalisations in children.

Authors:  Hannah C Moore; Nicholas de Klerk; Anthony D Keil; David W Smith; Christopher C Blyth; Peter Richmond; Deborah Lehmann
Journal:  J Paediatr Child Health       Date:  2011-11-14       Impact factor: 1.954

10.  WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.

Authors:  Kayvon Modjarrad; Birgitte Giersing; David C Kaslow; Peter G Smith; Vasee S Moorthy
Journal:  Vaccine       Date:  2015-06-20       Impact factor: 3.641

View more
  7 in total

1.  Meteorological factors and respiratory syncytial virus seasonality in subtropical Australia.

Authors:  C Morley; K Grimwood; S Maloney; R S Ware
Journal:  Epidemiol Infect       Date:  2018-03-21       Impact factor: 4.434

2.  Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England.

Authors:  Deborah Cromer; Albert Jan van Hoek; Anthony T Newall; Andrew J Pollard; Mark Jit
Journal:  Lancet Public Health       Date:  2017-07-31

3.  Respiratory syncytial virus hospitalization in children in northern Spain.

Authors:  Natividad Viguria; Iván Martínez-Baz; Laura Moreno-Galarraga; Luis Sierrasesúmaga; Blanca Salcedo; Jesús Castilla
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

4.  Air Pollution, housing and respirfatory tract Infections in Children: NatIonal birth Cohort study (PICNIC): study protocol.

Authors:  Graziella Favarato; Tom Clemens; Steven Cunningham; Chris Dibben; Alison Macfarlane; Ai Milojevic; Jonathon Taylor; Linda Petronella Martina Maria Wijlaars; Rachael Wood; Pia Hardelid
Journal:  BMJ Open       Date:  2021-05-03       Impact factor: 2.692

5.  The role of birth month in the burden of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in Croatia.

Authors:  You Li; Ena Batinović; Petra Milić; Joško Markić
Journal:  PLoS One       Date:  2022-09-02       Impact factor: 3.752

6.  Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis.

Authors:  David Hodgson; Richard Pebody; Jasmina Panovska-Griffiths; Marc Baguelin; Katherine E Atkins
Journal:  BMC Med       Date:  2020-11-18       Impact factor: 8.775

7.  Recommendations for respiratory syncytial virus surveillance at the national level.

Authors:  Anne C Teirlinck; Eeva K Broberg; Are Stuwitz Berg; Harry Campbell; Rachel M Reeves; AnnaSara Carnahan; Bruno Lina; Gatis Pakarna; Håkon Bøås; Hanna Nohynek; Hanne-Dorthe Emborg; Harish Nair; Janine Reiche; Jesus Angel Oliva; Joanne O'Gorman; John Paget; Karol Szymanski; Kostas Danis; Maja Socan; Manuel Gijon; Marie Rapp; Martina Havlíčková; Ramona Trebbien; Raquel Guiomar; Siddhivinayak S Hirve; Silke Buda; Sylvie van der Werf; Adam Meijer; Thea K Fischer
Journal:  Eur Respir J       Date:  2021-10-01       Impact factor: 16.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.